Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 358

1.

CD73 complexes with emmprin to regulate MMP-2 production from co-cultured sarcoma cells and fibroblasts.

Aoki M, Koga K, Miyazaki M, Hamasaki M, Koshikawa N, Oyama M, Kozuka-Hata H, Seiki M, Toole BP, Nabeshima K.

BMC Cancer. 2019 Sep 12;19(1):912. doi: 10.1186/s12885-019-6127-x.

2.

Unique Biological Activity and Potential Role of Monomeric Laminin-γ2 as a Novel Biomarker for Hepatocellular Carcinoma: A Review.

Yasuda H, Nakagawa M, Kiyokawa H, Yoshida E, Yoshimura T, Koshikawa N, Itoh F, Seiki M.

Int J Mol Sci. 2019 Jan 8;20(1). pii: E226. doi: 10.3390/ijms20010226. Review.

3.

Simple and cost-effective assay for isolating invasive living cells.

Takino T, Sato H, Seiki M.

Biotechniques. 2018 Sep;65(3):137-142. doi: 10.2144/btn-2018-0036.

4.

MT4-MMP deficiency increases patrolling monocyte recruitment to early lesions and accelerates atherosclerosis.

Clemente C, Rius C, Alonso-Herranz L, Martín-Alonso M, Pollán Á, Camafeita E, Martínez F, Mota RA, Núñez V, Rodríguez C, Seiki M, Martínez-González J, Andrés V, Ricote M, Arroyo AG.

Nat Commun. 2018 Mar 2;9(1):910. doi: 10.1038/s41467-018-03351-4.

5.

Identification of Proteolytic Cleavage Sites of EphA2 by Membrane Type 1 Matrix Metalloproteinase on the Surface of Cancer Cells.

Kikuchi K, Kozuka-Hata H, Oyama M, Seiki M, Koshikawa N.

Methods Mol Biol. 2018;1731:29-37. doi: 10.1007/978-1-4939-7595-2_3.

PMID:
29318540
6.

Specific detection of soluble EphA2 fragments in blood as a new biomarker for pancreatic cancer.

Koshikawa N, Minegishi T, Kiyokawa H, Seiki M.

Cell Death Dis. 2017 Oct 26;8(10):e3134. doi: 10.1038/cddis.2017.545.

7.

Development of a fully automated chemiluminescence immunoassay for urine monomeric laminin-γ2 as a promising diagnostic tool of non-muscle invasive bladder cancer.

Nakagawa M, Karashima T, Kamada M, Yoshida E, Yoshimura T, Nojima M, Inoue K, Shuin T, Seiki M, Koshikawa N.

Biomark Res. 2017 Oct 13;5:29. doi: 10.1186/s40364-017-0109-4. eCollection 2017.

8.

Developmental expression of membrane type 4-matrix metalloproteinase (Mt4-mmp/Mmp17) in the mouse embryo.

Blanco MJ, Rodríguez-Martín I, Learte AIR, Clemente C, Montalvo MG, Seiki M, Arroyo AG, Sánchez-Camacho C.

PLoS One. 2017 Sep 19;12(9):e0184767. doi: 10.1371/journal.pone.0184767. eCollection 2017.

9.

Therapy with transcutaneous administration of imiquimod combined with oral administration of sorafenib suppresses renal cell carcinoma growing in an orthotopic mouse model.

Karashima T, Udaka K, Niimura M, Suzuki K, Osakabe H, Shimamoto T, Fukata S, Inoue K, Kuroda N, Seiki M, Shuin T.

Oncol Lett. 2017 Jul;14(1):1162-1166. doi: 10.3892/ol.2017.6235. Epub 2017 May 24.

10.

Mint3 in bone marrow-derived cells promotes lung metastasis in breast cancer model mice.

Hara T, Murakami Y, Seiki M, Sakamoto T.

Biochem Biophys Res Commun. 2017 Aug 26;490(3):688-692. doi: 10.1016/j.bbrc.2017.06.102. Epub 2017 Jun 19.

PMID:
28634075
11.

Control of metastatic niche formation by targeting APBA3/Mint3 in inflammatory monocytes.

Hara T, Nakaoka HJ, Hayashi T, Mimura K, Hoshino D, Inoue M, Nagamura F, Murakami Y, Seiki M, Sakamoto T.

Proc Natl Acad Sci U S A. 2017 May 30;114(22):E4416-E4424. doi: 10.1073/pnas.1703171114. Epub 2017 May 15.

12.

Mint3-mediated L1CAM expression in fibroblasts promotes cancer cell proliferation via integrin α5β1 and tumour growth.

Nakaoka HJ, Tanei Z, Hara T, Weng JS, Kanamori A, Hayashi T, Sato H, Orimo A, Otsuji K, Tada K, Morikawa T, Sasaki T, Fukayama M, Seiki M, Murakami Y, Sakamoto T.

Oncogenesis. 2017 May 15;6(5):e334. doi: 10.1038/oncsis.2017.27.

13.

Serum monomeric laminin-γ2 as a novel biomarker for hepatocellular carcinoma.

Kiyokawa H, Yasuda H, Oikawa R, Okuse C, Matsumoto N, Ikeda H, Watanabe T, Yamamoto H, Itoh F, Otsubo T, Yoshimura T, Yoshida E, Nakagawa M, Koshikawa N, Seiki M.

Cancer Sci. 2017 Jul;108(7):1432-1439. doi: 10.1111/cas.13261. Epub 2017 Jun 2.

14.

Integrated functions of membrane-type 1 matrix metalloproteinase in regulating cancer malignancy: Beyond a proteinase.

Sakamoto T, Seiki M.

Cancer Sci. 2017 Jun;108(6):1095-1100. doi: 10.1111/cas.13231. Epub 2017 May 22. Review.

15.

Mint3/Apba3 depletion ameliorates severe murine influenza pneumonia and macrophage cytokine production in response to the influenza virus.

Uematsu T, Fujita T, Nakaoka HJ, Hara T, Kobayashi N, Murakami Y, Seiki M, Sakamoto T.

Sci Rep. 2016 Nov 24;6:37815. doi: 10.1038/srep37815.

16.

Mint3 potentiates TLR3/4- and RIG-I-induced IFN-β expression and antiviral immune responses.

Huai W, Song H, Yu Z, Wang W, Han L, Sakamoto T, Seiki M, Zhang L, Zhang Q, Zhao W.

Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):11925-11930. Epub 2016 Oct 3.

17.

New insight into the role of MMP14 in metabolic balance.

Mori H, Bhat R, Bruni-Cardoso A, Chen EI, Jorgens DM, Coutinho K, Louie K, Bowen BB, Inman JL, Tecca V, Lee SJ, Becker-Weimann S, Northen T, Seiki M, Borowsky AD, Auer M, Bissell MJ.

PeerJ. 2016 Jul 13;4:e2142. doi: 10.7717/peerj.2142. eCollection 2016.

18.

The ERK signaling target RNF126 regulates anoikis resistance in cancer cells by changing the mitochondrial metabolic flux.

Yoshino S, Hara T, Nakaoka HJ, Kanamori A, Murakami Y, Seiki M, Sakamoto T.

Cell Discov. 2016 Jul 26;2:16019. doi: 10.1038/celldisc.2016.19. eCollection 2016.

19.

Cortactin promotes exosome secretion by controlling branched actin dynamics.

Sinha S, Hoshino D, Hong NH, Kirkbride KC, Grega-Larson NE, Seiki M, Tyska MJ, Weaver AM.

J Cell Biol. 2016 Jul 18;214(2):197-213. doi: 10.1083/jcb.201601025. Epub 2016 Jul 11.

20.

NECAB3 Promotes Activation of Hypoxia-inducible factor-1 during Normoxia and Enhances Tumourigenicity of Cancer Cells.

Nakaoka HJ, Hara T, Yoshino S, Kanamori A, Matsui Y, Shimamura T, Sato H, Murakami Y, Seiki M, Sakamoto T.

Sci Rep. 2016 Mar 7;6:22784. doi: 10.1038/srep22784.

21.

Matrix metalloproteinase-14 mediates formation of bile ducts and hepatic maturation of fetal hepatic progenitor cells.

Otani S, Kakinuma S, Kamiya A, Goto F, Kaneko S, Miyoshi M, Tsunoda T, Asano Y, Kawai-Kitahata F, Nitta S, Nakata T, Okamoto R, Itsui Y, Nakagawa M, Azuma S, Asahina Y, Yamaguchi T, Koshikawa N, Seiki M, Nakauchi H, Watanabe M.

Biochem Biophys Res Commun. 2016 Jan 22;469(4):1062-8. doi: 10.1016/j.bbrc.2015.12.105. Epub 2015 Dec 24.

PMID:
26724533
22.

Matrix metalloproteinase 14 modulates signal transduction and angiogenesis in the cornea.

Chang JH, Huang YH, Cunningham CM, Han KY, Chang M, Seiki M, Zhou Z, Azar DT.

Surv Ophthalmol. 2016 Jul-Aug;61(4):478-97. doi: 10.1016/j.survophthal.2015.11.006. Epub 2015 Dec 2. Review.

23.

Urinary laminin-γ2 is a novel biomarker of non-muscle invasive urothelial carcinoma.

Kamada M, Koshikawa N, Minegishi T, Kawada C, Karashima T, Shuin T, Seiki M.

Cancer Sci. 2015 Dec;106(12):1730-7. doi: 10.1111/cas.12832. Epub 2015 Nov 6.

24.

MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer's disease.

Baranger K, Marchalant Y, Bonnet AE, Crouzin N, Carrete A, Paumier JM, Py NA, Bernard A, Bauer C, Charrat E, Moschke K, Seiki M, Vignes M, Lichtenthaler SF, Checler F, Khrestchatisky M, Rivera S.

Cell Mol Life Sci. 2016 Jan;73(1):217-36. doi: 10.1007/s00018-015-1992-1. Epub 2015 Jul 23.

25.

Proteolysis of EphA2 Converts It from a Tumor Suppressor to an Oncoprotein.

Koshikawa N, Hoshino D, Taniguchi H, Minegishi T, Tomari T, Nam SO, Aoki M, Sueta T, Nakagawa T, Miyamoto S, Nabeshima K, Weaver AM, Seiki M.

Cancer Res. 2015 Aug 15;75(16):3327-39. doi: 10.1158/0008-5472.CAN-14-2798. Epub 2015 Jun 30.

26.

Deficiency of MMP17/MT4-MMP proteolytic activity predisposes to aortic aneurysm in mice.

Martín-Alonso M, García-Redondo AB, Guo D, Camafeita E, Martínez F, Alfranca A, Méndez-Barbero N, Pollán Á, Sánchez-Camacho C, Denhardt DT, Seiki M, Vázquez J, Salaices M, Redondo JM, Milewicz D, Arroyo AG.

Circ Res. 2015 Jul 3;117(2):e13-26. doi: 10.1161/CIRCRESAHA.117.305108. Epub 2015 May 11.

PMID:
25963716
27.

Tropomodulin 1 expression driven by NF-κB enhances breast cancer growth.

Ito-Kureha T, Koshikawa N, Yamamoto M, Semba K, Yamaguchi N, Yamamoto T, Seiki M, Inoue J.

Cancer Res. 2015 Jan 1;75(1):62-72. doi: 10.1158/0008-5472.CAN-13-3455. Epub 2014 Nov 14.

28.

Evidence for the Involvement of MMP14 in MMP2 Processing and Recruitment in Exosomes of Corneal Fibroblasts.

Han KY, Dugas-Ford J, Seiki M, Chang JH, Azar DT.

Invest Ophthalmol Vis Sci. 2015 Aug;56(9):5323-9. doi: 10.1167/iovs.14-14417. Epub 2014 Jul 11.

29.

Investigation of a MMP-2 activity-dependent anchoring probe for nuclear imaging of cancer.

Temma T, Hanaoka H, Yonezawa A, Kondo N, Sano K, Sakamoto T, Seiki M, Ono M, Saji H.

PLoS One. 2014 Jul 10;9(7):e102180. doi: 10.1371/journal.pone.0102180. eCollection 2014.

30.

Basal localization of MT1-MMP is essential for epithelial cell morphogenesis in 3D collagen matrix.

Weaver SA, Wolters B, Ito N, Woskowicz AM, Kaneko K, Shitomi Y, Seiki M, Itoh Y.

J Cell Sci. 2014 Mar 15;127(Pt 6):1203-13. doi: 10.1242/jcs.135236. Epub 2014 Jan 24.

31.

Hypoxia-inducible factor 1 regulation through cross talk between mTOR and MT1-MMP.

Sakamoto T, Weng JS, Hara T, Yoshino S, Kozuka-Hata H, Oyama M, Seiki M.

Mol Cell Biol. 2014 Jan;34(1):30-42. doi: 10.1128/MCB.01169-13. Epub 2013 Oct 28.

32.

Critical role of transient activity of MT1-MMP for ECM degradation in invadopodia.

Watanabe A, Hoshino D, Koshikawa N, Seiki M, Suzuki T, Ichikawa K.

PLoS Comput Biol. 2013;9(5):e1003086. doi: 10.1371/journal.pcbi.1003086. Epub 2013 May 30. Erratum in: PLoS Comput Biol. 2013 Jun;9(6). doi:10.1371/annotation/b41ed85a-11d1-483a-a7ac-9d06f0c8669a. Hosino, Daisuke [corrected to Hoshino, Daisuke].

33.

MT1-MMP-dependent control of skeletal stem cell commitment via a β1-integrin/YAP/TAZ signaling axis.

Tang Y, Rowe RG, Botvinick EL, Kurup A, Putnam AJ, Seiki M, Weaver VM, Keller ET, Goldstein S, Dai J, Begun D, Saunders T, Weiss SJ.

Dev Cell. 2013 May 28;25(4):402-16. doi: 10.1016/j.devcel.2013.04.011. Epub 2013 May 16.

34.

[Prevention of tumour invasion].

Hoshino D, Koshikawa N, Seiki M, Taniguchi H.

Nihon Rinsho. 2012 Nov;70 Suppl 8:154-8. Japanese. No abstract available.

PMID:
23513830
35.

Hepatocyte growth factor activator inhibitor type 1 is a suppressor of intestinal tumorigenesis.

Hoshiko S, Kawaguchi M, Fukushima T, Haruyama Y, Yorita K, Tanaka H, Seiki M, Inatsu H, Kitamura K, Kataoka H.

Cancer Res. 2013 Apr 15;73(8):2659-70. doi: 10.1158/0008-5472.CAN-12-3337. Epub 2013 Feb 27.

36.

CDCP1 regulates the function of MT1-MMP and invadopodia-mediated invasion of cancer cells.

Miyazawa Y, Uekita T, Ito Y, Seiki M, Yamaguchi H, Sakai R.

Mol Cancer Res. 2013 Jun;11(6):628-37. doi: 10.1158/1541-7786.MCR-12-0544. Epub 2013 Feb 25.

37.

The phosphoinositide-binding protein ZF21 regulates ECM degradation by invadopodia.

Hoshino D, Nagano M, Saitoh A, Koshikawa N, Suzuki T, Seiki M.

PLoS One. 2013;8(1):e50825. doi: 10.1371/journal.pone.0050825. Epub 2013 Jan 31.

38.

Transmembrane/cytoplasmic, rather than catalytic, domains of Mmp14 signal to MAPK activation and mammary branching morphogenesis via binding to integrin β1.

Mori H, Lo AT, Inman JL, Alcaraz J, Ghajar CM, Mott JD, Nelson CM, Chen CS, Zhang H, Bascom JL, Seiki M, Bissell MJ.

Development. 2013 Jan 15;140(2):343-52. doi: 10.1242/dev.084236.

39.

Network analysis of the focal adhesion to invadopodia transition identifies a PI3K-PKCα invasive signaling axis.

Hoshino D, Jourquin J, Emmons SW, Miller T, Goldgof M, Costello K, Tyson DR, Brown B, Lu Y, Prasad NK, Zhang B, Mills GB, Yarbrough WG, Quaranta V, Seiki M, Weaver AM.

Sci Signal. 2012 Sep 11;5(241):ra66. doi: 10.1126/scisignal.2002964.

40.

Detection of the heterogeneous O-glycosylation profile of MT1-MMP expressed in cancer cells by a simple MALDI-MS method.

Shuo T, Koshikawa N, Hoshino D, Minegishi T, Ao-Kondo H, Oyama M, Sekiya S, Iwamoto S, Tanaka K, Seiki M.

PLoS One. 2012;7(8):e43751. doi: 10.1371/journal.pone.0043751. Epub 2012 Aug 22.

41.

Control and inhibition analysis of complex formation processes.

Saitou T, Itano K, Hoshino D, Koshikawa N, Seiki M, Ichikawa K, Suzuki T.

Theor Biol Med Model. 2012 Aug 3;9:33. doi: 10.1186/1742-4682-9-33.

42.

MT1-MMP plays a critical role in hematopoiesis by regulating HIF-mediated chemokine/cytokine gene transcription within niche cells.

Nishida C, Kusubata K, Tashiro Y, Gritli I, Sato A, Ohki-Koizumi M, Morita Y, Nagano M, Sakamoto T, Koshikawa N, Kuchimaru T, Kizaka-Kondoh S, Seiki M, Nakauchi H, Heissig B, Hattori K.

Blood. 2012 Jun 7;119(23):5405-16. doi: 10.1182/blood-2011-11-390849. Epub 2012 Apr 27.

PMID:
22544701
43.

Laser scanning-based tissue autofluorescence/fluorescence imaging (LS-TAFI), a new technique for analysis of microanatomy in whole-mount tissues.

Mori H, Borowsky AD, Bhat R, Ghajar CM, Seiki M, Bissell MJ.

Am J Pathol. 2012 Jun;180(6):2249-56. doi: 10.1016/j.ajpath.2012.02.032. Epub 2012 Apr 27.

44.

Cell adhesion in cancer.

Oh ES, Seiki M, Gotte M, Chung J.

Int J Cell Biol. 2012;2012:965618. doi: 10.1155/2012/965618. Epub 2012 Mar 20. No abstract available.

45.

Genetic screening of new genes responsible for cellular adaptation to hypoxia using a genome-wide shRNA library.

Yoshino S, Hara T, Weng JS, Takahashi Y, Seiki M, Sakamoto T.

PLoS One. 2012;7(4):e35590. doi: 10.1371/journal.pone.0035590. Epub 2012 Apr 16.

46.

Establishment and validation of computational model for MT1-MMP dependent ECM degradation and intervention strategies.

Hoshino D, Koshikawa N, Suzuki T, Quaranta V, Weaver AM, Seiki M, Ichikawa K.

PLoS Comput Biol. 2012;8(4):e1002479. doi: 10.1371/journal.pcbi.1002479. Epub 2012 Apr 12.

47.

Turnover of focal adhesions and cancer cell migration.

Nagano M, Hoshino D, Koshikawa N, Akizawa T, Seiki M.

Int J Cell Biol. 2012;2012:310616. doi: 10.1155/2012/310616. Epub 2012 Jan 26.

48.

The proteolytic activity of MT4-MMP is required for its pro-angiogenic and pro-metastatic promoting effects.

Host L, Paye A, Detry B, Blacher S, Munaut C, Foidart JM, Seiki M, Sounni NE, Noel A.

Int J Cancer. 2012 Oct 1;131(7):1537-48. doi: 10.1002/ijc.27436. Epub 2012 Apr 4.

49.

Mathematical modeling of invadopodia formation.

Saitou T, Rouzimaimaiti M, Koshikawa N, Seiki M, Ichikawa K, Suzuki T.

J Theor Biol. 2012 Apr 7;298:138-46. doi: 10.1016/j.jtbi.2011.12.018. Epub 2011 Dec 29.

PMID:
22212912
50.

VIP36 protein is a target of ectodomain shedding and regulates phagocytosis in macrophage Raw 264.7 cells.

Shirakabe K, Hattori S, Seiki M, Koyasu S, Okada Y.

J Biol Chem. 2011 Dec 16;286(50):43154-63. doi: 10.1074/jbc.M111.275586. Epub 2011 Oct 20. Erratum in: J Biol Chem. 2012 Jun 1;287(23):19340. J Biol Chem. 2014 Jul 11;289(28):19277.

Supplemental Content

Support Center